CytoDyn Forming Product Development Team For Rapid Development Of DNA Based Influenza Pre-Vaccines

SANTA FE, N.M.--(BUSINESS WIRE)--Sept. 8, 2006--CytoDyn, Inc. (OTCBB:CYDY) is forming a separate Product Development Team to expedite development of its licensed DNA Influenza Pre-Vaccines by its wholly owned subsidiary Advanced Influenza Technologies, Inc. Company scientists anticipate a potentially virulent seasonal flu as early as the winter of 2007 due to currently emerging mutations of Influenza A (the most common form of flu). Shan Lu, M.D., Ph.D., who invented the pre-vaccines, is expected to be a key member of the team.

Back to news